Pueblo police, Health Solutions’ alternative response model paying off – Pueblo Chieftain
Pueblo police, Health Solutions’ alternative response model paying off Pueblo Chieftain >View original article Contributor:
Pueblo police, Health Solutions’ alternative response model paying off Pueblo Chieftain >View original article Contributor:
The add-ons pile up: $93 for medications, $50 for cable TV. Prices soar as the industry leaves no service unbilled. The housing option is out of reach for many families. View original article Contributor: Jordan Rau
The facilities can look like luxury apartments or modest group homes, and can vary in pricing structures. Here’s a guide. View original article Contributor: Jordan Rau
The Food and Drug Administration (FDA) is investigating cinnamon apple puree and applesauce products amid reports of elevated blood lead levels in at least 34 individuals. Residents in more than 20 states have reported illness after exposure to cinnamon apple products offered by three brands: WanaBana, Weis, and Schnucks. The goods are manufactured in Ecuador … Read more
Amid a burgeoning neurodiversity movement, some say autistic children who are nonverbal and intellectually disabled are being left behind. View original article Contributor: Katherine Ellison
Women’s body temperatures are no more variable than men’s, researchers found. View original article Contributor: Erin Blakemore
A new study sheds light on what works best to prevent migraine attacks, and surprisingly, cheaper medicines worked as well as the expensive ones. View original article Contributor:
With winter on its way, dry, chapped skin is a bigger concern for many people this time of year, due to lower humidity. Even though Miami has a humid climate, … Click to Continue » View original article Contributor:
The financial burden of high insulin costs that patients and insurers face is often blamed on the Food and Drug Administration’s (FDA) regulatory framework, but a new study suggests pharmaceutical companies have also been using patenting processes to unfairly maintain high costs. In the FDA’s master list of approved medications, devices, and other therapeutics, a … Read more
The move is the latest step by federal agencies to address shortages of the therapy as the country heads deeper into respiratory virus season. View original article Contributor: Sabrina Malhi